Neuberger Berman Group’s Abiomed Inc ABMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,173	Closed	-$1.03M	–	1911
2022 Q3	$1.03M	Buy	4,173 +1,577	+61%	+$426K	﹤0.01%	1250
2022 Q2	$644K	Buy	2,596 +1,197	+86%	+$323K	﹤0.01%	1430
2022 Q1	$464K	Buy	1,399 +241	+21%	+$74.2K	﹤0.01%	1557
2021 Q4	$268K	Buy	+1,158	New	+$391K	﹤0.01%	1760
2019 Q3	–	Sell	-99,790	Closed	-$26M	–	1620
2019 Q2	$26M	Sell	99,790 -50,296	-34%	-$13.3M	0.03%	535
2019 Q1	$42.9M	Sell	150,086 -582	-0.4%	-$193K	0.05%	421
2018 Q4	$49M	Buy	150,668 +7,131	+5%	+$2.48M	0.07%	364
2018 Q3	$64.6M	Sell	143,537 -19,275	-12%	-$7.6M	0.07%	349
2018 Q2	$66.6M	Sell	162,812 -48,272	-23%	-$17.5M	0.07%	345
2018 Q1	$61.4M	Sell	211,084 -39,253	-16%	-$9.95M	0.07%	362
2017 Q4	$46.9M	Sell	250,337 -33,256	-12%	-$6.21M	0.05%	427
2017 Q3	$47.8M	Sell	283,593 -255	-0.1%	-$38.6K	0.06%	404
2017 Q2	$40.7M	Buy	283,848 +52,405	+23%	+$7.04M	0.05%	430
2017 Q1	$29M	Buy	231,443 +89,183	+63%	+$10.3M	0.04%	512
2016 Q4	$16M	Buy	142,260 +134,051	+1,633%	+$15.5M	0.02%	645
2016 Q3	$1.06M	Sell	8,209 -3,500	-30%	-$419K	﹤0.01%	1092
2016 Q2	$1.28M	Buy	11,709 +2,709	+30%	+$270K	﹤0.01%	1039
2016 Q1	$853K	Buy	9,000 +6,515	+262%	+$550K	﹤0.01%	1132
2015 Q4	$224K	Buy	+2,485	New	+$211K	﹤0.01%	1430
2014 Q1	–	Sell	-8,220	Closed	-$220K	–	1680
2013 Q4	$220K	Sell	8,220 -2,707	-25%	-$66.9K	﹤0.01%	1514
2013 Q3	$208K	Buy	+10,927	New	+$250K	﹤0.01%	1513

Other funds holding ABMD